ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: PO1027

Reusing Occluded Veins: Inside-Out Central Venous Access for Hemodialysis, Our Institutional Experience

Session Information

Category: Dialysis

  • 703 Dialysis: Vascular Access


  • Chishti, Emad A., University of Kentucky Medical Center, Lexington, Kentucky, United States
  • Alagusundaramoorthy, Sayee Sundar, University of Kentucky Medical Center, Lexington, Kentucky, United States

Central venous occlusion is a challenge in end-stage renal disease (ESRD) patients dependent on hemodialysis. The inside-out central venous access (IOCVA) procedure is an established method of re-using occluded veins.


Retrospective single-center study examining characteristics of patients with ESRD who underwent IOCVA between 01/01/2017 – 05/01/2021. All procedures were performed with moderate conscious sedation by an interventional cardiologist or nephrologist.


46 IOCVA procedures were performed in 39 ESRD patients. All procedures were performed to re-use the occluded right internal jugular vein (RIJ) for tunneled dialysis catheter placement. Mean patient age was 58 ± 14.6 years. 20 (51.3%) patients were male. Hypertension and diabetes were comorbid conditions in 29 (74.4%) and 20 (51.3%) patients, respectively. A total of 7 (17.9%) patients had prior kidney transplant. The average number of prior vascular accesses (defined as venous access or arteriovenous fistula/graft) in patients prior to IOCVA was 2.6 ± 1.7 (range 1-9). 9 (23.1%) had two prior accesses, and 30 (76.9%) had >3 prior accesses. 5 (12.8%) patients had >1 prior IOCVA procedure. 5 (12.8%) patients had complete superior vena cava occlusion. 17 (43.6%) patients had failed AVF/AVG and 2 (5.1%) had failed translumbar venous access. Technical success rate was 100% with no complications.


The RIJ vein is the most effective and durable site for long-term hemodialysis access. Occlusion, stenosis of this vein can lead to a downward spiral of access crisis with venous exhaustion resulting in trans-lumbar or trans-hepatic catheter placement for dialysis. These approaches are associated with high rates of dysfunction as well as infection, catheter migration and thrombosis. The transhepatic approach can also cause life-threatening intraperitoneal hemorrhage. The use of IOCVA alleviates the need to sacrifice subsequent veins and allows for the occluded RIJ to be re-accessed as many times as needed via the femoral vein. Our data provides further evidence in support of the safety and efficacy of IOCVA for long-term hemodialysis access in ESRD patients.